KD Logo

Keeping an Eye on AbCellera Biologics Inc (ABCL) After Insider Trading Activity

In the meantime, The Benchmark Company downgraded its AbCellera Biologics Inc [ABCL] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in late February from “a Hold” to “a Buy”. KeyBanc Capital Markets began covering ABCL with “an Overweight” recommendation on December 05, 2023. The Benchmark Company revised its rating on November 06, 2023. It rated ABCL as “a Hold” which previously was an “a Buy”.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Price Performance Review of ABCL

On Tuesday, AbCellera Biologics Inc [NASDAQ:ABCL] saw its stock jump 1.87% to $2.73. Over the last five days, the stock has gained 5.81%. AbCellera Biologics Inc shares have fallen nearly -52.19% since the year began. Nevertheless, the stocks have fallen -48.88% over the past one year. While a 52-week high of $6.05 was reached on 01/08/24, a 52-week low of $2.34 was recorded on 09/10/24. SMA at 50 days reached $2.81, while 200 days put it at $4.07.

Levels Of Support And Resistance For ABCL Stock

The 24-hour chart illustrates a support level at 2.64, which if violated will result in even more drops to 2.54. On the upside, there is a resistance level at 2.85. A further resistance level may holdings at 2.96. The Relative Strength Index (RSI) on the 14-day chart is 53.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 26.17%. Stochastics %K at 80.91% indicates the stock is a selling.

How much short interest is there in AbCellera Biologics Inc?

A steep rise in short interest was recorded in AbCellera Biologics Inc stocks on 2024-08-30, growing by 0.14 million shares to a total of 17.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 17.42 million shares. There was a rise of 0.77%, which implies that there is a positive sentiment for the stock.

Most Popular